Home › Funds › LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE › CRL

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE position in CRL

CHARLES RIV LABS INTL INC · Health Care

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE reported holding 26,634 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$7.9M, representing 2.18% of its reported portfolio and ranking #20 among its reported holdings. LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)26.63K sh
Reported value held$7.86M
Portfolio Weight2.18%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE's CRL position evolved

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE first disclosed a stake in CRL in Q3 2023 at 55,334 shares (US$10.8M). The position peaked in Q1 2024 at 55,158 shares, worth US$14.9M. Across 13 filings, LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE increased the stake 3 time(s), trimmed it 7 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 26,634 shares valued at US$7.9M — a reduction of -1,370 shares quarter over quarter.. Notable position changes include a 37% trim in Q4 2025 (shares fell 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 55.33K $10.84M New
Q4 2023 55.32K $13.08M Hold
Q1 2024 55.16K $14.95M Hold
Q2 2024 55.46K $11.46M Add
Q3 2024 56.53K $11.14M Add
Q4 2024 55.04K $10.16M Reduce
Q1 2025 55.99K $8.43M Add
Q2 2025 50.47K $7.66M Reduce
Q3 2025 49.91K $7.81M Reduce
Q4 2025 31.64K $6.31M Reduce
Q1 2026 28.53K $4.92M Reduce
Q2 2026 28.00K $6.35M Reduce
Q3 2026 26.63K $7.86M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CRL and 13F data

CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 29 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CRL

All CRL fund holders →

FAQ

How long has LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE held CRL?

LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE's current position in CRL?

As of Q3 2026, LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE holds 26.63K shares of CRL (CHARLES RIV LABS INTL INC), valued at $7.86M, representing 2.18% of its reported portfolio and ranking #20.

Has LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE been buying or selling CRL?

In the latest 13F filing (Q3 2026), LAWSON KROEKER INVESTMENT MANAGEMENT INC/NE reduced its position in CRL. The position peaked in Q1 2024 at 55.16K shares.

Which other funds hold CRL?

Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.